# Dexmedetomidine Versus Propofol for Sedation in Stereotactic Brain Biopsy

> **NCT03375385** · PHASE4 · COMPLETED · sponsor: **Ain Shams University** · enrollment: 60 (actual)

## Conditions studied

- Adverse Effects in the Therapeutic Use of Other and Unspecified Agents Primarily Acting on the Respiratory System

## Interventions

- **DRUG:** dexmedetomidine/ propofol

## Key facts

- **NCT ID:** NCT03375385
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09
- **Primary completion:** 2017-12
- **Final completion:** 2017-12
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2022-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03375385

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03375385, "Dexmedetomidine Versus Propofol for Sedation in Stereotactic Brain Biopsy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03375385. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*